Detalhe da pesquisa
1.
Immune checkpoint inhibitors in elderly patients with lung cancer: evidence from phase 3 trials.
Curr Opin Oncol
; 36(1): 35-43, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37975311
2.
PMS2 amplification contributes brain metastasis from lung cancer.
Biol Proced Online
; 26(1): 12, 2024 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38714954
3.
Does caring for patients with advanced non-small cell lung cancer affect health-related quality of life of caregivers? A multicenter, cross-sectional study.
BMC Public Health
; 24(1): 224, 2024 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38238722
4.
Special issue "The advance of solid tumor research in China": Real-world clinical outcomes of alectinib for advanced nonsmall-cell lung cancer patients with ALK fusion in China.
Int J Cancer
; 152(1): 15-23, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35579989
5.
The predictive value of inflammatory biomarkers for major pathological response in non-small cell lung cancer patients receiving neoadjuvant chemoimmunotherapy and its association with the immune-related tumor microenvironment: a multi-center study.
Cancer Immunol Immunother
; 72(3): 783-794, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36056951
6.
Progress in diagnosis and treatment of checkpoint inhibitor pneumonitis.
Curr Opin Oncol
; 35(1): 31-36, 2023 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36322006
7.
Extracellular Vesicles for Drug Delivery in Cancer Treatment.
Biol Proced Online
; 25(1): 28, 2023 Nov 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37946166
8.
Influence of Exosomes on Astrocytes in the Pre-Metastatic Niche of Lung Cancer Brain Metastases.
Biol Proced Online
; 25(1): 5, 2023 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36859173
9.
Full spectrum flow cytometry-powered comprehensive analysis of PBMC as biomarkers for immunotherapy in NSCLC with EGFR-TKI resistance.
Biol Proced Online
; 25(1): 21, 2023 Jul 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37488517
10.
Analytics and applications of polyglycerol polyricinoleate (PGPR)-Current research progress.
Compr Rev Food Sci Food Saf
; 22(6): 4282-4301, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37583303
11.
Treatment efficacy of HER2-mutant lung adenocarcinoma by immune checkpoint inhibitors: a multicenter retrospective study.
Cancer Immunol Immunother
; 71(7): 1625-1631, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34743223
12.
Increased blood-based intratumor heterogeneity (bITH) is associated with unfavorable outcomes of immune checkpoint inhibitors plus chemotherapy in non-small cell lung cancer.
BMC Med
; 20(1): 256, 2022 07 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35902848
13.
Treatment of small cell lung cancer: recent advances.
Curr Opin Oncol
; 34(1): 83-88, 2022 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34698669
14.
Reduced frequencies of Foxp3+GARP+ regulatory T cells in COPD patients are associated with multi-organ loss of tissue phenotype.
Respir Res
; 23(1): 176, 2022 Jul 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35780120
15.
A Metabolism-Related Gene Prognostic Index for Prediction of Response to Immunotherapy in Lung Adenocarcinoma.
Int J Mol Sci
; 23(20)2022 Oct 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36293001
16.
Dexamethasone reduces autoantibody levels in MRL/lpr mice by inhibiting Tfh cell responses.
J Cell Mol Med
; 25(17): 8329-8337, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34318604
17.
Reactive oxygen species scavenging and inflammation mitigation enabled by biomimetic prussian blue analogues boycott atherosclerosis.
J Nanobiotechnology
; 19(1): 161, 2021 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34059078
18.
Exosomes transmit T790M mutation-induced resistance in EGFR-mutant NSCLC by activating PI3K/AKT signalling pathway.
J Cell Mol Med
; 24(2): 1529-1540, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31894895
19.
Use of aspirin in the prevention of colorectal cancer through TIGIT-CD155 pathway.
J Cell Mol Med
; 23(7): 4514-4522, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31090213
20.
EGFR-targeted therapy alters the tumor microenvironment in EGFR-driven lung tumors: Implications for combination therapies.
Int J Cancer
; 145(5): 1432-1444, 2019 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30784054